Data scientists at the Icahn School of Medicine at Mount Sinai in New York and colleagues have created an artificial intelligence model that may more accurately predict which existing medicines, not currently classified as harmful, may in fact lead to congenital disabilities.
Researchers discuss the concept of immunodiagnosis and explores the potential of artificial intelligence in ID systems for precise tumor immunotherapy.
Two students on the Master's Degree in Bioinformatics and Biostatistics at the Universitat Oberta de Catalunya (UOC) have developed a mobile app capable of detecting in a matter of seconds whether someone is suffering from glaucoma, diabetic retinopathy or cataracts, three of the world's most common causes of vision loss and blindness.
MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today announced the launch of a global brand campaign titled “What If?” at the XXIII International Congress of Genetics (ICG), a five-yearly conference to bring together the international genetics community from around the world.